JP2024524895A5 - - Google Patents
Info
- Publication number
- JP2024524895A5 JP2024524895A5 JP2023576368A JP2023576368A JP2024524895A5 JP 2024524895 A5 JP2024524895 A5 JP 2024524895A5 JP 2023576368 A JP2023576368 A JP 2023576368A JP 2023576368 A JP2023576368 A JP 2023576368A JP 2024524895 A5 JP2024524895 A5 JP 2024524895A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- sequence described
- csp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211820P | 2021-06-17 | 2021-06-17 | |
| US63/211,820 | 2021-06-17 | ||
| PCT/US2022/033877 WO2022266383A1 (en) | 2021-06-17 | 2022-06-16 | Anti-csp antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524895A JP2024524895A (ja) | 2024-07-09 |
| JP2024524895A5 true JP2024524895A5 (enExample) | 2025-06-23 |
Family
ID=84526612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023576368A Pending JP2024524895A (ja) | 2021-06-17 | 2022-06-16 | 抗ｃｓｐ抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11655290B2 (enExample) |
| EP (1) | EP4355774A4 (enExample) |
| JP (1) | JP2024524895A (enExample) |
| KR (1) | KR20240047964A (enExample) |
| CN (1) | CN117940450A (enExample) |
| AU (2) | AU2022292722B2 (enExample) |
| IL (1) | IL309422A (enExample) |
| MX (1) | MX2023014984A (enExample) |
| WO (1) | WO2022266383A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024214379A1 (en) * | 2023-02-03 | 2025-08-21 | Atreca, Inc. | Anti-csp antibody variants |
| WO2025194069A1 (en) * | 2024-03-15 | 2025-09-18 | Atreca, Inc. | Anti-csp antibody variants |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2927892A (en) | 1991-11-16 | 1993-06-15 | Smithkline Beecham Biologicals (Sa) | Hybrid protein between cs from plasmodium and hbsag |
| DK1071700T3 (da) | 1998-04-20 | 2010-06-07 | Glycart Biotechnology Ag | Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| CA2742969A1 (en) | 2008-11-07 | 2010-05-14 | Fabrus Llc | Anti-dll4 antibodies and uses thereof |
| CN103732738A (zh) * | 2011-04-28 | 2014-04-16 | 小利兰斯坦福大学托管委员会 | 与样品相关的多核苷酸的鉴定 |
| TW201708260A (zh) | 2015-07-22 | 2017-03-01 | 優瑞卡醫療公司 | 靶向ｐｓａ胜肽／ｍｈｃ複合體之構築體及其用途 |
| US11066464B2 (en) * | 2016-03-21 | 2021-07-20 | Kymab Limited | Anti-malarial antibodies that bind circumsporozoite protein |
| US20220195023A1 (en) | 2019-02-19 | 2022-06-23 | Atreca, Inc. | Anti-csp antibody variants |
-
2022
- 2022-06-16 CN CN202280053427.0A patent/CN117940450A/zh active Pending
- 2022-06-16 EP EP22825865.3A patent/EP4355774A4/en active Pending
- 2022-06-16 JP JP2023576368A patent/JP2024524895A/ja active Pending
- 2022-06-16 KR KR1020247001320A patent/KR20240047964A/ko active Pending
- 2022-06-16 IL IL309422A patent/IL309422A/en unknown
- 2022-06-16 WO PCT/US2022/033877 patent/WO2022266383A1/en not_active Ceased
- 2022-06-16 US US17/842,351 patent/US11655290B2/en active Active
- 2022-06-16 AU AU2022292722A patent/AU2022292722B2/en active Active
- 2022-06-16 MX MX2023014984A patent/MX2023014984A/es unknown
-
2023
- 2023-01-26 US US18/101,933 patent/US12545723B2/en active Active
-
2025
- 2025-08-19 AU AU2025220692A patent/AU2025220692A1/en active Pending